Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group

Our objective was to determine whether oral etoposide and cisplatin combination (EoP) is superior to paclitaxel in the treatment of advanced breast cancer (ABC) patients pretreated with anthracyclines. From December 1997 to August 2003, 201 patients were randomised, 100 to EoP and 101 to paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Icli, F, Akbulut, H, Uner, A, Yalcin, B, Baltali, E, Altinbas, M, Coşkun, Ş, Komurcu, S, Erkisi, M, Demirkazik, A, Senler, F C, Sencan, O, Büyükcelik, A, Boruban, C, Onur, H, Zengin, N, Sak, S D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361864/
https://www.ncbi.nlm.nih.gov/pubmed/15726120
http://dx.doi.org/10.1038/sj.bjc.6602388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361864/
https://www.ncbi.nlm.nih.gov/pubmed/15726120
http://dx.doi.org/10.1038/sj.bjc.6602388

Ejemplares similares